Stockreport

Gilead increases enrollment target for remdesivir trial in COVID-19 patients [Reuters]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead increases enrollment target for remdesivir trial in COVID-19 patients (Reuters) - Gilead Sciences Inc on Friday increased enrollment target by 3,600 for a trial t [Read more]